Advancements in therapeutic peptides: Shaping the future of cancer treatment
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2024
DOI: 10.1016/j.bbcan.2024.189197 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2024. Verfasst von Xiaojie Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, The First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology, Luoyang …. Hauptthemen laut MEDLINE: Neoplasms, Peptides. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 192 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Henan Province Natural Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
In the evolving landscape of cancer treatment, therapeutic peptides are assuming to play an increasingly vital role. Although the number of peptide drugs available for clinical cancer treatment is currently limited, extensive preclinical research is underway, presenting a promising trajectory for the future. The collaborative efforts of natural anti-cancer peptides (ACPs) and synthetic ACPs, propelled by advancements in molecular biology and peptide chemistry, are steering remarkable progress in this domain. We explores the intricate mechanisms underlying the anti-cancer effects of these peptides. The exploration of innovative strategies, including cancer immunotherapy and advanced drug delivery systems, is likely to contribute to the increasing presenceuse of peptide drugs in clinical cancer care. Furthermore, we delve into the potential implications and challenges associated with this anticipated shift, emphasizing the need for continued research and development to unlock the full therapeutic potential of peptide drugs in cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences, The First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology, Luoyang 471003, China; China-US (Henan) Hormel Cancer Institute, Zhengzhou 450…
- School of Basic Medical Sciences, The First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology, Luoyang 471003, China.
- China-US (Henan) Hormel Cancer Institute, Zhengzhou 450003, China.
- China-US (Henan) Hormel Cancer Institute, Zhengzhou 450003, China; Research Center of Basic Medicine Sciences, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, China.
- China-US (Henan) Hormel Cancer Institute, Zhengzhou 450003, China; Research Center of Basic Medicine Sciences, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, China. Electronic address: dongzg@…
Förderung
- Henan Province Natural Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Chen, X., Zhao, Z., Laster, K. V., Liu, K., & Dong, Z. (2024). Advancements in therapeutic peptides: Shaping the future of cancer treatment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2024.189197
Vancouver
Chen X, Zhao Z, Laster KV, Liu K, Dong Z. Advancements in therapeutic peptides: Shaping the future of cancer treatment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2024. doi:10.1016/j.bbcan.2024.189197
BibTeX
@article{Chen2024,
author = {Chen, Xiaojie and Zhao, Zhiwei and Laster, Kyle Vaughn and Liu, Kangdong and Dong, Zigang},
title = {Advancements in therapeutic peptides: Shaping the future of cancer treatment},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2024},
doi = {10.1016/j.bbcan.2024.189197}
}
EUVIMED